RLMD
USDRelmada Therapeutics Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$2.210
Kõrge
$2.810
Madal
$2.190
Maht
0.98M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
91.9M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
0.74M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
CORAL GABLES, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company")), a clinical-stage biotechnology company advancing innovative therapies for oncology and
Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer
Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC FDA feedback supports 2 potential registrational trials – 1) a registrational trial in 2nd line refractory BCG-unresponsive NMIBC, and 2) a randomized
Seotud aktsiad
ATMV
AlphaVest Acquisition Corp Ordinary Shares
IPDN
Professional Diversity Network Inc.
OXLCZ
Oxford Lane Capital Corp. 5.00% Notes due 2027
WTFCP
Wintrust Financial Corporation Depositary Shares Each Representing a 1/1000th Interest in a Share of 6.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series E
SOHOB
Sotherly Hotels Inc. 8.0% Series B Cumulative Redeemable Perpetual Preferred Stock
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.